Copyright

biologic therapies, immunomodulators, inflammatory bowel disease, pediatric
dx.doi.org/10.1097/MIB.0000000000000245, hdl.handle.net/1765/88112
Inflammatory Bowel Diseases
Department of Pediatrics

Cozijnsen, M.A, Escher, J.C, Griffiths, A, Turner, D, & de Ridder, L. (2015). Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases (Vol. 21, pp. 951–961). doi:10.1097/MIB.0000000000000245